Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Impact of Race, Socioeconomic Status, and Clinicopathologic Features on Clinical Outcomes in Triple-Negative Breast Cancer in the ECOG-ACRIN EA1131 Trial.
Journal: JCO oncology advances
Published: May 18, 2026
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.
Journal: Cancer
Published: August 07, 2023
Reply to T. Shimoi et al and Y. Shimanuki et al.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 23, 2021
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 07, 2021
Posterior reversible encephalopathy syndrome in a postpartum woman with acute lymphoblastic leukaemia after intrathecal methotrexate.
Journal: BMJ case reports
Published: October 06, 2017
The impact of Agent Orange exposure on prognosis and management in patients with chronic lymphocytic leukemia: a National Veteran Affairs Tumor Registry Study.
Journal: Leukemia & lymphoma
Published: September 15, 2017
The Language of End-of-Life Decision Making: A Simulation Study.
Journal: Journal of palliative medicine
Published: July 18, 2015
Differences in Physicians' Verbal and Nonverbal Communication With Black and White Patients at the End of Life.
Journal: Journal of pain and symptom management
Published: March 22, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026